<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00950625</url>
  </required_header>
  <id_info>
    <org_study_id>091026SUR</org_study_id>
    <nct_id>NCT00950625</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Analgesia After Laparoscopic Cholecystectomy</brief_title>
  <official_title>Comparison of Analgesic Efficacy of Intra-peritoneal Lignocaine With Bupivacaine After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although laparoscopic cholecystectomy is associated with less pain than contemporary open
      procedures; it is definitely not pain free and the magnitude of postoperative shoulder and
      abdominal pain in the early postoperative period is still quite significant. This
      postoperative pain is a major concern not only for the patients, but also healthcare workers;
      and it often contributes to overnight hospital stay after this minimally invasive surgical
      procedure. Intraperitoneal instillation of local anesthetics at the time of surgery to
      control pain after laparoscopic cholecystectomy has been extensively studied in numerous
      randomized trials and found to be extremely useful. Lignocaine and Bupivacaine are two
      commonly used local anesthetic agents. In view of contradictory results from previous
      studies, it is not yet clear which of these two agents is superior to the other for pain
      control in this setting. To answer this question, we have designed a prospective randomized
      controlled trial and the specific aim of the study is to compare the analgesic efficacy of
      intraperitoneal lignocaine with intraperitoneal Bupivacaine in the postoperative setting
      after laparoscopic cholecystectomy.

      If we can improve pain control after this minimally invasive procedure, it might result in
      decreased postoperative requirement of narcotic analgesia and its associated side-effects. It
      may also result in early recovery and the same day discharge of the patients with significant
      cost-containment for the patient and healthcare systems in future.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Control after Laparoscopic Cholecystectomy</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Requirement of Analgesia after laparoscopic cholecystectomy</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Laparoscopic Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>intraperitoneal lignocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraperitoneal lignocaine will be compared with intraperitoneal bupevacaine for pain control after laparoscopic cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intraperitoneal bupevacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intraperitoneal lignocaine will be compared with intraperitoneal bupevacaine after laparoscopic cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lignocaine</intervention_name>
    <description>200 mg of intraperitoneal lignocaine will be given once during surgery</description>
    <arm_group_label>intraperitoneal lignocaine</arm_group_label>
    <arm_group_label>intraperitoneal bupevacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupevacaine</intervention_name>
    <description>100 mg of bupevacaine will be given once during laparoscopic cholecystectomy</description>
    <arm_group_label>intraperitoneal lignocaine</arm_group_label>
    <arm_group_label>intraperitoneal bupevacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of symptomatic gallstones requiring laparoscopic cholecystectomy

          -  Elective surgical procedure

          -  American Society of Anesthesiologists class I and II

        Exclusion Criteria:

          -  Patients refusing randomization

          -  Patients already on analgesics

          -  Patients with acute cholecystitis

          -  Patients requiring preoperative cholangiogram or common bile duct exploration

          -  Patients having bile or stone spillage during procedure

          -  Patients requiring conversion to open procedure

          -  Patients requiring re-exploration for any reason

          -  Patients with history of allergy to local anesthetic agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad R Khan, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>74800</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2009</study_first_submitted>
  <study_first_submitted_qc>July 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2009</study_first_posted>
  <last_update_submitted>January 24, 2011</last_update_submitted>
  <last_update_submitted_qc>January 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2011</last_update_posted>
  <responsible_party>
    <name_title>Muhammad Rizwan Khan</name_title>
    <organization>Aga Khan University</organization>
  </responsible_party>
  <keyword>intraperitoneal analgesia</keyword>
  <keyword>laparoscopic cholecystectomy</keyword>
  <keyword>lignocaine</keyword>
  <keyword>bupevacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

